P-THER PAN Trademark

Trademark Overview

On Friday, March 28, 2025, a trademark application was filed for P-THER PAN with the United States Patent and Trademark Office. The USPTO has given the P-THER PAN trademark a serial number of 79422643. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 1, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The P-THER PAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical trials; clinical research; clinical research services; testing of pharmaceuticals.
p-ther pan

General Information

Serial Number79422643
Word MarkP-THER PAN
Filing DateFriday, March 28, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, May 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkP THER PAN
Goods and ServicesClinical trials; clinical research; clinical research services; testing of pharmaceuticals.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 1, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Thursday, May 1, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, May 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, May 4, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

ther clinical research pharmaceuticals testing services trials